[1] 金其庄，王玉柱，叶朝阳，等. 中国血液透析用血管通路专家共识(第2版)[J]. 中国血液净化,2019,18(06):365-381.
[2] Gilmore J. KDOQI clinical practice guidelines and clinical practice recommendations--2006 updates[J]. Nephrol Nurs J,2006,33(5):487-488.
[3] Saeed M, Newman G E, Mccann R L, et al. Stenoses in dialysis fistulas: treatment with percutaneous angioplasty[J]. Radiology,1987,164(3):693-697.
[4] Aktas A, Bozkurt A, Aktas B, et al. Percutaneous transluminal balloon angioplasty in stenosis of native hemodialysis arteriovenous fistulas: technical success and analysis of factors affecting postprocedural fistula patency[J]. Diagn Interv Radiol,2015,21(2):160-166.
[5] Zhou M, Chen G, Feng L, et al. Effects of ultrasound-guided percutaneous transluminal angioplasty for stenosis of arteriovenous fistula used for hemodialysis and related factors influencing patency[J]. Ann Ital Chir,2020,91:55-60.
[6] 李伟宏，蒋雅楠，王珺，等. 血管成形术治疗前臂自体动静脉内瘘狭窄的临床效果[J]. 中华实用诊断与治疗杂志,2019,33(10):987-989.
[7] Quencer K B, Arici M. Arteriovenous Fistulas and Their Characteristic Sites of Stenosis[J]. AJR Am J Roentgenol,2015,205(4):726-734.
[8] Kwon H, Choi J Y, Ko H K, et al. Comparison of surgical and endovascular salvage procedures for juxta-anastomotic stenosis in autogenous wrist radiocephalic arteriovenous fistula[J]. Ann Vasc Surg,2014,28(8):1840-1846.
[9] 何剑，秦凯炜. 经皮腔内血管成形术与手术治疗血液透析患者自体动静脉内瘘狭窄的效果比较[J]. 临床医药文献电子杂志,2019,6(28):56-57.
[10] 余燕婷，高占辉，赵刘兵，等. 经皮腔内血管成形术与手术治疗血液透析患者自体动静脉内瘘狭窄的临床效果比较[J]. 医学研究生学报,2017,30(12):1305-1308.
[11] 王世超，施娅雪. 血液透析通路头静脉弓狭窄的诊治现状[J]. 中国血液净化,2019,18(10):713-716.
[12] Neves M, Outerelo C, Pereira M, et al. Predictive factors of recurrent endovascular intervention for cephalic arch stenosis after percutaneous transluminal angioplasty[J]. J Vasc Surg,2018,68(3):836-842.
[13] Tang T Y, Tan C S, Yap C, et al. Helical stent (SUPERA?) and drug-coated balloon (Passeo-18 Lux?) for recurrent cephalic arch stenosis: Rationale and design of arch V SUPERA-LUX Study[J]. J Vasc Access,2019:1197789067.
[14] Yang T Y, Cheng H W, Weng H H, et al. Percutaneous transluminal angioplasty for radial-cephalic fistulae with stenosis at the arteriovenous junction[J]. Am J Med Sci,2012,343(6):435-439.
[15] Lu M, Li H, Feng J, et al. Ultrasound-Guided Pharmacomechanical Thrombolysis and Angioplasty for Treatment of Acute Thrombotic Prosthetic Arteriovenous Access: 5-Year Experience with 154 Procedures in a Single Center[J]. Ultrasound Med Biol,2018,44(11):2314-2322.
[16] Park J, Kim J, Hwang S, et al. Arteriovenous graft patency outcomes and prognostic factors[J]. Vascular,2019,27(2):128-134.
[17] Macchi E, Fontana F, Beneventi A, et al. Efficacy of Primary Stent-Graft Placement in the Treatment of Vascular Access Graft Outflow Tract Stenosis[J]. Vasc Endovascular Surg,2020,54(1):25-35.
[18] 王耿，陈志强，李孝虎，等. 高压球囊对比普通球囊治疗自体动静脉内瘘狭窄疗效的前瞻性分析[J]. 中国血管外科杂志(电子版),2016,8(01):53-56.
[19] Aftab S A, Tay K H, Irani F G, et al. Randomized clinical trial of cutting balloon angioplasty versus high-pressure balloon angioplasty in hemodialysis arteriovenous fistula stenoses resistant to conventional balloon angioplasty[J]. J Vasc Interv Radiol,2014,25(2):190-198.
[20] Agarwal S K, Nadkarni G N, Yacoub R, et al. Comparison of Cutting Balloon Angioplasty and Percutaneous Balloon Angioplasty of Arteriovenous Fistula Stenosis: A Meta-Analysis and Systematic Review of Randomized Clinical Trials[J]. J Interv Cardiol,2015,28(3):288-295.
[21] 孙晓磊，马亚蓉，何虎强，等. VascuTrak~(TM)球囊导管在自体动静脉内瘘顽固性狭窄闭塞治疗中的应用[J]. 介入放射学杂志,2016,25(07):590-594.
[22] Rasuli P, Chennur V S, Connolly M J, et al. Randomized Trial Comparing the Primary Patency following Cutting Versus High-Pressure Balloon Angioplasty for Treatment of de Novo Venous Stenoses in Hemodialysis Arteriovenous Fistulae[J]. J Vasc Interv Radiol,2015,26(12):1840-1846.
[23] Bukka M, Rednam P J, Sinha M. Drug-eluting balloon: design, technology and clinical aspects[J]. Biomed Mater,2018,13(3):32001.
[24] Abdul S S, Tran H, Thongprayoon C, et al. Comparison of drug-coated balloon angioplasty versus conventional angioplasty for arteriovenous fistula stenosis: Systematic review and meta-analysis[J]. J Vasc Access,2019:1197792044.
[25] Kennedy S A, Mafeld S, Baerlocher M O, et al. Drug-Coated Balloon Angioplasty in Hemodialysis Circuits: A Systematic Review and Meta-Analysis[J]. J Vasc Interv Radiol,2019,30(4):483-494.
[26] Khawaja A Z, Cassidy D B, Al S J, et al. Systematic review of drug eluting balloon angioplasty for arteriovenous haemodialysis access stenosis[J]. J Vasc Access,2016,17(2):103-110.
[27] Yan W I, Yap H Y, Hsien T L, et al. A systematic review and meta-analysis of drug-coated balloon versus conventional balloon angioplasty for dialysis access stenosis[J]. J Vasc Surg,2019,70(3):970-979.
[28] Yuan Y, Cheng W, Lu H. Drug-Eluting Balloon Versus Plain Balloon Angioplasty For The Treatment of Failing Hemodialysis Access: A Systematic Review and Meta-analysis[J]. Ann Vasc Surg,2019.
[29] Irani F G, Teo T, Tay K H, et al. Hemodialysis Arteriovenous Fistula and Graft Stenoses: Randomized Trial Comparing Drug-eluting Balloon Angioplasty with Conventional Angioplasty[J]. Radiology,2018,289(1):238-247.
[30] Dinh K, Limmer A M, Paravastu S, et al. Mortality After Paclitaxel-Coated Device Use in Dialysis Access: A Systematic Review and Meta-Analysis[J]. J Endovasc Ther,2019,26(5):600-612.
[31] Rokoszak V, Syed M H, Salata K, et al. A systematic review and meta-analysis of plain versus drug-eluting balloon angioplasty in the treatment of juxta-anastomotic hemodialysis arteriovenous fistula stenosis[J]. J Vasc Surg,2020,71(3):1046-1054.
[32] Haave T R, Manstad-Hulaas F, Brekken R. Treatment of restenosis in radiocephalic arteriovenous hemodialysis fistulas: percutaneous transluminal angioplasty or drug-coated balloon[J]. Acta Radiol,2019,60(11):1584-1589.
[33] Liao M T, Lee C P, Lin T T, et al. A randomized controlled trial of drug-coated balloon angioplasty in venous anastomotic stenosis of dialysis arteriovenous grafts[J]. J Vasc Surg,2019.
[34] Tordoir J, Zonnebeld N, van Loon M M, et al. Surgical and Endovascular Intervention for Dialysis Access Maturation Failure During and After Arteriovenous Fistula Surgery: Review of the Evidence[J]. Eur J Vasc Endovasc Surg,2018,55(2):240-248.
[35] Miyamoto K, Sato T, Momohara K, et al. Analysis of factors for post-percutaneous transluminal angioplasty primary patency rate in hemodialysis vascular access[J]. J Vasc Access,2020:1196760101.
[36] Marmagkiolis K, Iliescu C, Edupuganti M, et al. Primary Patency With Stenting Versus Balloon Angioplasty for Arteriovenous Graft Failure: A Systematic Review and Meta-Analysis[J]. J Invasive Cardiol,2019,31(12):E356-E361.
[37] Cildag M B, Cildag S, Koseoglu O F. The Relationship Between Neutrophil-Lymphocyte Ratio and Primary Patency of Percutaneous Transluminal Angioplasty in Hemodialysis Arteriovenous Fistula Stenosis When Using Conventional and Drug-Eluting Balloons[J]. Cardiovasc Intervent Radiol,2016,39(12):1702-1707.
[38] Wu C C, Chen T Y, Hsieh M Y, et al. Monocyte Chemoattractant Protein-1 Levels and Postangioplasty Restenosis of Arteriovenous Fistulas[J]. Clin J Am Soc Nephrol,2017,12(1):113-121.
[39] 张丽红，王玉柱. 超声引导PTA在动静脉内瘘狭窄中的应用[J]. 中国血液净化,2016,15(06):321-323.
[40] 彭嘉欣，万恒，刘正军. 经皮腔内血管成形术治疗人工血管移植物内瘘狭窄或闭塞的疗效[J]. 中国普通外科杂志,2019,28(12):1497-1506.
[41] Han Y M, Kim K Y, Chung B H, et al. Rupture, Breakdown, and Pulmonary Artery Embolism of a Balloon Catheter Tip during Percutaneous Transluminal Angioplasty of Arteriovenous Fistula[J]. Vasc Specialist Int,2019,35(4):245-250.
[42] Kaneko Y, Yanagawa T, Taru Y, et al. Subclavian steal syndrome in a hemodialysis patient after percutaneous transluminal angioplasty of arteriovenous access[J]. J Vasc Access,2018,19(4):404-408
